Dr Reddys Laboratories (RDY) Short-term Investments (2017 - 2026)
Dr Reddys Laboratories has reported Short-term Investments over the past 10 years, most recently at $75.5 million for Q1 2026.
- For Q1 2026, Short-term Investments rose 408.11% year-over-year to $75.5 million; the TTM value through Mar 2026 reached $75.5 million, up 408.11%, while the annual FY2026 figure was $75.5 million, 977.98% up from the prior year.
- Short-term Investments for Q1 2026 was $75.5 million at Dr Reddys Laboratories, up from $14.9 million in the prior quarter.
- Over five years, Short-term Investments peaked at $681.5 million in Q1 2023 and troughed at $2.0 million in Q1 2024.
- A 5-year average of $159.8 million and a median of $25.3 million in 2022 define the central range for Short-term Investments.
- Biggest five-year swings in Short-term Investments: skyrocketed 2588.38% in 2023 and later crashed 99.7% in 2024.
- Year by year, Short-term Investments stood at $25.3 million in 2022, then skyrocketed by 2588.38% to $681.5 million in 2023, then crashed by 99.7% to $2.0 million in 2024, then skyrocketed by 629.76% to $14.9 million in 2025, then skyrocketed by 408.11% to $75.5 million in 2026.
- Business Quant data shows Short-term Investments for RDY at $75.5 million in Q1 2026, $14.9 million in Q1 2025, and $2.0 million in Q1 2024.